Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 SAD Safety and PK Study of TNX-201 in Healthy Volunteers
NCT02290379Phase 1Completed
- Sponsor
- Tonix Pharmaceuticals
- Start
- Nov 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of dexisometheptene mucate in tension-type headache (TTH) (5 arms), sponsored by Tonix Pharmaceuticals. Primary endpoints: Plasma levels of isometheptene or metabolites and Number of Adverse events. Started Nov 2014; status: completed.
02
Drugs
dexisometheptene mucate
03
Conditions
tension-type headache (TTH)
Beyond the preview
Go deeper on NCT02290379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02290379.